Peter Ashley Marks Insider Profile
4 Followers
Peter Ashley Marks, Director at Alterity Therapeutics, holds 191.34K shares in Alterity Therapeutics (Ticker: ATHE). Most recently, Peter Ashley Marks Bought 47,620 shares of Alterity Therapeutics on Sep 08, 2026 for an estimated value of $23.81K.
Peter Ashley Marks has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Peter Ashley Marks's holdings
Insider Roles
Director
Roles that Peter Ashley Marks holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Peter Ashley Marks
Peter Ashley Marks's Trading History
List of latest transactions for each holding click on a transaction to see Peter Ashley Marks's performance on stock
You May Also Like
Peter Ashley Marks insider profile FAQ
What is the percentage of profitable transactions made by Peter Ashley Marks?
The percentage of profitable transactions made by Peter Ashley Marks is ―.
What is the average return per transaction made by Peter Ashley Marks?
The average return per transaction made by Peter Ashley Marks is ―.
What stocks does Peter Ashley Marks hold?
Peter Ashley Marks holds: ATHE stocks.
What was Peter Ashley Marks’s latest transaction?
Peter Ashley Marks latest transaction was an Informative Buy of $23.81K.
What was Peter Ashley Marks's most profitable transaction?
Peter Ashley Marks’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Peter Ashley Marks's role in Alterity Therapeutics?
Peter Ashley Marks's role in Alterity Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.